Immunotherapy Biosimilar

Samsung Bioepis,Immunotherapy Biosimilar,Keytruda,Vision,Challenges

Pioneering the Future of Cancer Treatment: Samsung Bioepis Accelerates Development of Keytruda Biosimilar

SOUTH KOREA 4월 7, 2024 • 0 Comment
In the high-stakes world of biopharmaceuticals, Samsung Bioepis is setting the pace by intensifying its development efforts for a biosimilar…